FTLF
FITLIFE BRANDS, INC.
Company overview
- Market capitalization
- $87.24M
- Employees
- 81
- Latest publication
- 2026-09-29
About FITLIFE BRANDS, INC.
FitLife Brands, Inc. provides nutritional supplements and wellness products for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; general wellness products with an emphasis on natural, vegan, and organic ingredients; male health and weight loss products; energy products; general health supplements; and natural skincare and beauty products; supplements focused on targeted nutrition; supplements for weight loss, cleansing and sexual health, and total body wellness. It markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, Maritime Naturals, MusclePharm, Irwin Naturals, Applied Nutrition, and Nature's Secret through franchised stores, as well as through retail locations, which include specialty, mass, and online, and e-commerce platform. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 26,549,000USD | 25,325,000USD | 25,910,000USD | 23,485,000USD | 16,127,000USD | 15,936,000USD | 15,013,000USD | 15,977,000USD |
| Cost Of Revenue | 16,738,000USD | 16,056,000USD | 16,971,000USD | 14,749,000USD | 9,223,000USD | 9,062,000USD | 8,801,000USD | 8,976,000USD |
| Gross Profit | 9,811,000USD | 9,269,000USD | 8,939,000USD | 8,736,000USD | 6,904,000USD | 6,874,000USD | 6,212,000USD | 7,001,000USD |
| Selling General Administrative | 4,755,000USD | 3,718,000USD | 4,934,000USD | 2,748,000USD | 2,485,000USD | 2,512,000USD | 2,291,000USD | 2,645,000USD |
| Selling And Marketing Expenses | 1,449,000USD | 1,245,000USD | 1,259,000USD | 1,357,000USD | 1,191,000USD | 1,053,000USD | 979,000USD | 1,093,000USD |
| Total Operating Expenses | 6,456,000USD | 6,208,000USD | 6,444,000USD | 6,418,000USD | 4,386,000USD | 3,916,000USD | 3,331,000USD | 3,819,000USD |
| Operating Income | 3,355,000USD | 3,061,000USD | 2,495,000USD | 2,318,000USD | 2,518,000USD | 2,958,000USD | 2,881,000USD | 3,182,000USD |
| Total Other Income Expense Net | -671,000USD | -714,000USD | -1,113,000USD | -568,000USD | -140,000USD | -239,000USD | -230,000USD | -286,000USD |
| Interest Expense | 679,000USD | 735,000USD | 814,000USD | 580,000USD | 225,000USD | 244,000USD | 282,000USD | 326,000USD |
| Income Before Tax | 2,684,000USD | 2,347,000USD | 1,382,000USD | 1,750,000USD | 2,378,000USD | 2,719,000USD | 2,651,000USD | 2,896,000USD |
| Income Tax Expense | 734,000USD | 627,000USD | -258,000USD | 829,000USD | 631,000USD | 701,000USD | 581,000USD | 770,000USD |
| Net Income | 1,950,000USD | 1,720,000USD | 1,640,000USD | 921,000USD | 1,747,000USD | 2,018,000USD | 2,070,000USD | 2,126,000USD |
| Unclassified Operating Expenses | — | 1,245,000USD | — | 2,313,000USD | — | — | — | — |
| Net Interest Income | — | -735,000USD | -810,000USD | -562,000USD | -175,000USD | -218,000USD | -254,000USD | -307,000USD |
| Tax Provision | — | 627,000USD | -258,000USD | 829,000USD | 631,000USD | 701,000USD | 581,000USD | 770,000USD |
| Net Income From Continuing Ops | — | 1,720,000USD | 1,640,000USD | 921,000USD | 1,747,000USD | 2,018,000USD | 2,070,000USD | 2,126,000USD |
| Ebit | — | 3,061,000USD | 2,196,000USD | 2,330,000USD | 2,603,000USD | 2,963,000USD | 2,933,000USD | 3,222,000USD |
| Ebitda | — | 3,309,000USD | 2,447,000USD | 2,466,000USD | 2,617,000USD | 2,982,000USD | 2,956,000USD | 3,244,000USD |
| Depreciation And Amortization | — | 248,000USD | 251,000USD | 136,000USD | 14,000USD | 19,000USD | 23,000USD | 22,000USD |
| Reconciled Depreciation | — | 248,000USD | 251,000USD | 136,000USD | 14,000USD | 19,000USD | 23,000USD | 22,000USD |
| Interest Income | — | — | 4,000USD | 18,000USD | 50,000USD | 26,000USD | 28,000USD | 19,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 81,458,000USD | 64,469,000USD | 52,700,000USD | 28,803,000USD | 27,913,000USD | 21,744,000USD | 19,497,000USD | 17,077,000USD |
| Cost Of Revenue | 50,005,000USD | 36,389,000USD | 31,268,000USD | 16,769,000USD | 15,409,000USD | 12,350,000USD | 11,436,000USD | 10,332,000USD |
| Gross Profit | 31,453,000USD | 28,080,000USD | 21,432,000USD | 12,034,000USD | 12,504,000USD | 9,394,000USD | 8,061,000USD | 6,745,000USD |
| Selling General Administrative | 14,036,000USD | 5,346,000USD | 7,885,000USD | 6,267,000USD | 3,651,000USD | 3,047,000USD | 3,049,000USD | 3,333,000USD |
| Selling And Marketing Expenses | 4,860,000USD | 4,626,000USD | 4,276,000USD | — | 2,564,000USD | 2,105,000USD | 2,379,000USD | 2,690,000USD |
| Total Operating Expenses | 19,316,000USD | 14,961,000USD | 13,882,000USD | 6,333,000USD | 6,274,000USD | 5,190,000USD | 5,480,000USD | 6,092,000USD |
| Operating Income | 12,137,000USD | 13,119,000USD | 7,550,000USD | 5,701,000USD | 6,230,000USD | 4,204,000USD | 2,581,000USD | 653,000USD |
| Interest Income | 98,000USD | 69,000USD | 331,000USD | 121,000USD | 25,000USD | 9,000USD | — | — |
| Interest Expense | 1,863,000USD | 1,367,000USD | 1,025,000USD | 121,000USD | 25,000USD | 15,000USD | 47,000USD | 133,000USD |
| Net Interest Income | -1,765,000USD | -1,298,000USD | -267,000USD | -121,000USD | -25,000USD | -6,000USD | -47,000USD | -133,000USD |
| Income Before Tax | 8,229,000USD | 11,871,000USD | 7,003,000USD | 5,822,000USD | 6,708,000USD | 4,268,000USD | 2,617,000USD | 520,000USD |
| Income Tax Expense | 1,903,000USD | 2,887,000USD | 1,707,000USD | 1,393,000USD | 1,298,000USD | -4,446,000USD | 7,000USD | 11,000USD |
| Tax Provision | 1,903,000USD | 2,887,000USD | 1,817,000USD | 1,393,000USD | 1,298,000USD | -4,446,000USD | 7,000USD | 11,000USD |
| Net Income | 6,326,000USD | 8,984,000USD | 5,296,000USD | 4,429,000USD | 5,410,000USD | 8,825,000USD | 2,698,000USD | 509,000USD |
| Net Income From Continuing Ops | 6,326,000USD | 8,984,000USD | 4,289,000USD | 4,429,000USD | 5,410,000USD | 8,714,000USD | 2,698,000USD | 509,000USD |
| Ebit | 10,092,000USD | 13,238,000USD | 8,028,000USD | 5,701,000USD | 6,230,000USD | 4,283,000USD | 2,664,000USD | 653,000USD |
| Ebitda | 10,512,000USD | 13,346,000USD | 8,122,000USD | 5,767,000USD | 6,289,000USD | 4,321,000USD | 2,716,000USD | 722,000USD |
| Depreciation And Amortization | 420,000USD | 108,000USD | 94,000USD | 66,000USD | 59,000USD | 38,000USD | 52,000USD | 69,000USD |
| Reconciled Depreciation | 420,000USD | 108,000USD | 81,000USD | 66,000USD | 59,000USD | 117,000USD | 223,000USD | 69,000USD |
| Total Other Income Expense Net | -3,908,000USD | -1,248,000USD | -547,000USD | -121,000USD | -478,000USD | 64,000USD | 36,000USD | -133,000USD |
| Unclassified Operating Expenses | — | 4,989,000USD | 1,721,000USD | — | — | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | 4,429,000USD | 5,410,000USD | 8,714,000USD | 2,635,000USD | 404,000USD |
| Non Operating Income Net Other | — | — | — | — | — | 79,000USD | 171,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 102,592,000USD | 104,269,000USD | 106,320,000USD | 109,984,000USD | 62,847,000USD | 62,193,000USD | 58,531,000USD | 58,587,000USD |
| Total Current Assets | 30,550,000USD | 31,640,000USD | 33,069,000USD | 37,400,000USD | 22,177,000USD | 21,759,000USD | 18,143,000USD | 18,099,000USD |
| Other Current Assets | 1,414,000USD | 1,142,000USD | 1,334,000USD | 2,021,000USD | 6,437,000USD | 994,000USD | 950,000USD | 998,000USD |
| Other Non Current Assets | 88,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 55,218,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 20,913,000USD | 20,812,000USD | 21,610,000USD | 33,025,000USD | 12,968,000USD | 13,296,000USD | 11,311,000USD | 12,055,000USD |
| Total Stockholder Equity | 47,374,000USD | 45,381,000USD | 43,639,000USD | 41,892,000USD | 40,919,000USD | 38,918,000USD | 36,126,000USD | 34,158,000USD |
| Total Equity Including Noncontrolling Interest | 47,374,000USD | — | — | — | — | — | — | — |
| Net Receivables | 6,977,000USD | 7,778,000USD | 8,765,000USD | 9,640,000USD | 2,488,000USD | 2,693,000USD | 1,651,000USD | 2,066,000USD |
| Inventory | 21,070,000USD | 21,528,000USD | 21,324,000USD | 22,227,000USD | 11,722,000USD | 12,131,000USD | 11,074,000USD | 10,371,000USD |
| Property Plant Equipment Net | 559,000USD | 687,000USD | 810,000USD | 920,000USD | 448,000USD | 474,000USD | 487,000USD | 522,000USD |
| Goodwill | 19,333,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 50,952,000USD | 51,196,000USD | 51,440,000USD | 51,648,000USD | 26,285,000USD | 26,234,000USD | 26,235,000USD | 26,314,000USD |
| Accounts Payable | 6,614,000USD | 6,451,000USD | 6,911,000USD | 9,148,000USD | 4,940,000USD | 5,275,000USD | 4,067,000USD | 4,078,000USD |
| Short Term Debt | 252,000USD | 6,435,000USD | 6,527,000USD | 14,523,000USD | 4,574,000USD | 4,581,000USD | 4,581,000USD | 4,589,000USD |
| Common Stock | 94,000USD | 94,000USD | 94,000USD | 94,000USD | 94,000USD | 94,000USD | 92,000USD | 46,000USD |
| Retained Earnings | 15,563,000USD | 13,613,000USD | 11,893,000USD | 10,253,000USD | 9,332,000USD | 7,585,000USD | 5,567,000USD | 3,497,000USD |
| Total Liab | — | 58,888,000USD | 62,681,000USD | 68,092,000USD | 21,928,000USD | 23,275,000USD | 22,405,000USD | 24,429,000USD |
| Other Current Liab | — | 6,432,000USD | 6,468,000USD | 7,666,000USD | 1,933,000USD | 1,695,000USD | 1,248,000USD | 1,527,000USD |
| Capital Stock | — | 94,000USD | 94,000USD | 94,000USD | 94,000USD | 94,000USD | 92,000USD | 46,000USD |
| Good Will | — | 19,363,000USD | 19,393,000USD | 19,366,000USD | 13,116,000USD | 13,035,000USD | 13,022,000USD | 13,130,000USD |
| Cash | — | 1,192,000USD | 1,646,000USD | 3,512,000USD | 1,530,000USD | 5,941,000USD | 4,468,000USD | 4,664,000USD |
| Cash And Short Term Investments | — | 1,192,000USD | 1,646,000USD | 3,512,000USD | 1,530,000USD | 5,941,000USD | 4,468,000USD | 4,664,000USD |
| Net Debt | — | 41,035,000USD | 43,602,000USD | 43,759,000USD | 9,664,000USD | 6,388,000USD | 8,994,000USD | 9,941,000USD |
| Short Long Term Debt | — | 6,094,000USD | 6,094,000USD | 14,094,000USD | 4,500,000USD | 4,500,000USD | 4,500,000USD | 4,500,000USD |
| Short Long Term Debt Total | — | 42,227,000USD | 45,248,000USD | 47,271,000USD | 11,194,000USD | 12,329,000USD | 13,462,000USD | 14,605,000USD |
| Long Term Debt | — | 35,534,000USD | 38,449,000USD | 32,363,000USD | 6,321,000USD | 7,436,000USD | 8,550,000USD | 9,664,000USD |
| Property Plant Equipment Gross | — | 1,451,000USD | 1,551,000USD | 1,854,000USD | 1,360,000USD | 1,373,000USD | 1,376,000USD | 1,396,000USD |
| Accumulated Other Comprehensive Income | — | -556,000USD | -561,000USD | -596,000USD | -522,000USD | -633,000USD | -662,000USD | -428,000USD |
| Common Stock Shares Outstanding | — | 9,991,000shares | 9,977,000shares | 9,997,000shares | 9,961,000shares | 9,926,000shares | 9,210,000shares | 9,930,000shares |
| Non Current Assets Total | — | 72,629,000USD | 73,251,000USD | 72,584,000USD | 40,670,000USD | 40,434,000USD | 40,388,000USD | 40,488,000USD |
| Non Current Liabilities Total | — | 38,075,999USD | 41,071,000USD | 35,067,000USD | 8,960,000USD | 9,979,000USD | 11,094,000USD | 12,374,000USD |
| Non Currrent Assets Other | — | 89,000USD | 83,000USD | 83,000USD | — | — | — | — |
| Net Working Capital | — | 10,828,000USD | 11,459,000USD | 4,375,000USD | 9,209,000USD | 8,463,000USD | 6,832,000USD | 6,044,000USD |
| Unclassified Non Current Assets | — | 1,294,000USD | 1,525,000USD | — | — | — | — | — |
| Unclassified Current Liabilities | — | -4,600,000USD | -4,390,000USD | -12,406,000USD | -2,979,000USD | -2,755,000USD | -3,085,000USD | -2,639,000USD |
| Unclassified Non Current Liabilities | — | 2,541,999USD | 2,622,000USD | 2,704,000USD | 2,639,000USD | 2,543,000USD | 2,544,000USD | 2,710,000USD |
| Unclassified Equity | — | 32,136,000USD | 32,119,000USD | 32,047,000USD | 31,921,000USD | 31,778,000USD | 31,037,000USD | 30,997,000USD |
| Current Deferred Revenue | — | — | — | — | — | -81,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 106,320,000USD | 58,531,000USD | 55,346,000USD | 25,707,000USD | 21,507,000USD | 16,774,000USD | 6,326,000USD | 5,862,000USD |
| Intangible Assets | 51,440,000USD | 26,235,000USD | 26,309,000USD | 150,000USD | 192,000USD | — | — | — |
| Other Current Assets | 1,334,000USD | 950,000USD | 1,398,000USD | 295,000USD | 322,000USD | 52,000USD | 72,000USD | 446,000USD |
| Total Liab | 62,681,000USD | 22,405,000USD | 28,310,000USD | 4,319,000USD | 4,161,000USD | 4,740,000USD | 2,984,000USD | 3,548,000USD |
| Total Stockholder Equity | 43,639,000USD | 36,126,000USD | 27,036,000USD | 21,388,000USD | 17,346,000USD | 12,034,000USD | 3,342,000USD | 2,314,000USD |
| Other Current Liab | 6,468,000USD | 1,248,000USD | 1,597,000USD | 1,156,000USD | 632,000USD | 833,000USD | 256,000USD | 866,000USD |
| Common Stock | 94,000USD | 92,000USD | 92,000USD | 46,000USD | 46,000USD | 12,000USD | 12,000USD | 111,000USD |
| Capital Stock | 94,000USD | 92,000USD | 46,000USD | 45,000USD | 46,000USD | 12,000USD | 12,000USD | 111,000USD |
| Retained Earnings | 11,893,000USD | 5,567,000USD | -3,417,000USD | -13,202,000USD | -13,142,000USD | -18,392,000USD | -27,106,000USD | -29,804,000USD |
| Good Will | 19,393,000USD | 13,022,000USD | 13,294,000USD | 358,000USD | 358,000USD | 225,000USD | 225,000USD | 225,000USD |
| Cash | 1,646,000USD | 4,468,000USD | 1,139,000USD | 13,277,000USD | 9,897,000USD | 6,336,000USD | 265,000USD | 259,000USD |
| Cash And Short Term Investments | 1,646,000USD | 4,468,000USD | 1,139,000USD | 9,897,000USD | — | 6,336,000USD | 265,000USD | 259,000USD |
| Total Current Assets | 33,069,000USD | 18,143,000USD | 14,693,000USD | 17,657,000USD | 17,684,000USD | 11,873,000USD | 5,701,000USD | 5,438,000USD |
| Total Current Liabilities | 21,610,000USD | 11,311,000USD | 10,337,000USD | 4,091,000USD | 4,058,000USD | 4,129,000USD | 2,776,000USD | 3,548,000USD |
| Net Debt | 43,602,000USD | 8,994,000USD | 19,008,000USD | -9,739,000USD | — | -5,675,000USD | -11,000USD | 241,000USD |
| Short Term Debt | 6,527,000USD | 4,581,000USD | 4,587,000USD | 55,000USD | — | 50,000USD | 46,000USD | 500,000USD |
| Short Long Term Debt | 6,094,000USD | 4,500,000USD | 4,500,000USD | — | — | — | — | 500,000USD |
| Short Long Term Debt Total | 45,248,000USD | 13,462,000USD | 20,147,000USD | 158,000USD | — | 661,000USD | 254,000USD | 500,000USD |
| Long Term Debt | 38,449,000USD | 8,550,000USD | 15,509,000USD | — | — | 453,000USD | — | — |
| Net Receivables | 8,765,000USD | 1,651,000USD | 3,065,000USD | 945,000USD | 945,000USD | 2,084,000USD | 2,366,000USD | 1,879,000USD |
| Inventory | 21,324,000USD | 11,074,000USD | 9,091,000USD | 6,520,000USD | 6,520,000USD | 3,401,000USD | 2,998,000USD | 3,523,000USD |
| Accounts Payable | 6,911,000USD | 4,067,000USD | 3,261,000USD | 2,880,000USD | 2,880,000USD | 3,246,000USD | 2,010,000USD | 2,628,000USD |
| Property Plant Equipment Net | 810,000USD | 487,000USD | 258,000USD | 46,000USD | 70,000USD | 98,000USD | 136,000USD | 189,000USD |
| Property Plant Equipment Gross | 1,551,000USD | 1,376,000USD | 1,072,000USD | 902,000USD | 902,000USD | 902,000USD | 902,000USD | 902,000USD |
| Accumulated Other Comprehensive Income | -561,000USD | -662,000USD | -292,000USD | 0USD | — | 0USD | 0USD | -713,000USD |
| Common Stock Shares Outstanding | 9,977,000shares | 9,898,000shares | 9,810,000shares | 4,974,596shares | 4,801,730shares | 4,549,396shares | 1,092,312shares | 875,486shares |
| Non Current Assets Total | 73,251,000USD | 40,388,000USD | 40,653,000USD | 3,823,000USD | 3,823,000USD | 4,901,000USD | 625,000USD | 424,000USD |
| Non Current Liabilities Total | 41,071,000USD | 11,094,000USD | 17,973,000USD | 103,000USD | 103,000USD | 611,000USD | 208,000USD | 0USD |
| Non Currrent Assets Other | 83,000USD | — | 792,000USD | 1,847,000USD | — | 208,000USD | 10,000USD | 10,000USD |
| Net Working Capital | 11,459,000USD | 6,832,000USD | 4,356,000USD | 18,933,000USD | 13,566,000USD | 7,744,000USD | 2,925,000USD | 1,890,000USD |
| Unclassified Non Current Assets | 1,525,000USD | — | — | 1,422,000USD | — | — | — | — |
| Unclassified Current Liabilities | -4,390,000USD | -3,085,000USD | -4,500,000USD | — | — | — | — | — |
| Unclassified Non Current Liabilities | 2,622,000USD | 2,544,000USD | 2,464,000USD | — | — | — | — | — |
| Unclassified Equity | 32,119,000USD | 31,037,000USD | 30,607,000USD | 34,499,000USD | 30,396,000USD | 32,192,000USD | 32,043,000USD | 32,609,000USD |
| Current Deferred Revenue | — | — | 892,000USD | — | — | — | 464,000USD | — |
| Non Current Liabilities Other | — | — | — | 49,000USD | — | 158,000USD | 208,000USD | — |
| Net Tangible Assets | — | — | — | 21,388,000USD | 16,796,000USD | 11,809,000USD | 3,117,000USD | 2,089,000USD |
| Unclassified Current Assets | — | — | — | -3,380,000USD | — | — | — | — |
| Other Assets | — | — | — | — | 3,045,000USD | 4,370,000USD | 10,000USD | 10,000USD |
| Treasury Stock | — | — | — | — | — | -1,790,000USD | -1,619,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 500,000USD |
| Change To Account Receivables | 1,723,000USD |
| Change To Inventory | 494,000USD |
| Change To Liabilities | -471,000USD |
| Change In Working Capital | 1,921,000USD |
| Operating Cash Flow | 6,119,000USD |
| Capital Expenditures | 0USD |
| Investing Cash Flow | 0USD |
| Financing Cash Flow | -6,647,000USD |
| Effect Of Forex Changes On Cash | -29,000USD |
| Change In Cash | -557,000USD |
| End Cash Flow | 1,089,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 1,720,000USD | 1,640,000USD | 921,000USD | 1,747,000USD | 2,018,000USD | 2,070,000USD | 2,126,000USD | 2,628,000USD |
| Depreciation | 248,000USD | 251,000USD | 195,000USD | 14,000USD | 19,000USD | 23,000USD | 22,000USD | 27,000USD |
| Stock Based Compensation | 17,000USD | 72,000USD | 126,000USD | 99,000USD | 107,000USD | 115,000USD | 141,000USD | 101,000USD |
| Other Non Cash Items | -21,000USD | 1,346,000USD | 3,225,000USD | -7,000USD | -16,000USD | 46,000USD | 30,000USD | -61,000USD |
| Change To Account Receivables | 921,000USD | 890,000USD | 129,000USD | 253,000USD | -1,062,000USD | 343,000USD | 498,000USD | -238,000USD |
| Change To Inventory | 16,000USD | 278,000USD | -353,000USD | 506,000USD | -1,013,000USD | -886,000USD | -582,000USD | -859,000USD |
| Change In Working Capital | 537,000USD | -2,361,000USD | -795,000USD | -658,000USD | 200,000USD | -1,297,000USD | -272,000USD | -1,125,000USD |
| Total Cash From Operating Activities | 2,484,000USD | 244,000USD | 3,672,000USD | 1,195,000USD | 2,328,000USD | 957,000USD | 2,047,000USD | 1,570,000USD |
| Capital Expenditures | 0USD | -5,000USD | -8,000USD | -5,000USD | -24,000USD | 0USD | 0USD | 0USD |
| Free Cash Flow | 2,484,000USD | 239,000USD | 3,664,000USD | 1,190,000USD | 2,304,000USD | 957,000USD | 2,047,000USD | 1,570,000USD |
| Net Borrowings | -2,924,000USD | -1,923,000USD | 35,577,000USD | -1,125,000USD | -1,125,000USD | -1,125,000USD | -1,125,000USD | — |
| Total Cash From Financing Activities | -2,924,000USD | -1,923,000USD | 35,577,000USD | -702,000USD | -866,000USD | -1,108,000USD | -1,125,000USD | -1,125,000USD |
| Change In Cash | -454,000USD | -1,866,000USD | 1,927,000USD | -4,409,000USD | 1,474,000USD | -200,000USD | 985,000USD | 445,000USD |
| Begin Period Cash Flow | 1,646,000USD | 3,512,000USD | 1,585,000USD | 5,994,000USD | 4,520,000USD | 4,720,000USD | 3,735,000USD | 3,290,000USD |
| End Period Cash Flow | 1,192,000USD | 1,646,000USD | 3,512,000USD | 1,585,000USD | 5,994,000USD | 4,520,000USD | 4,720,000USD | 3,735,000USD |
| Total Cashflows From Investing Activities | — | -5,000USD | -37,508,000USD | -5,005,000USD | -24,000USD | — | — | — |
| Other Cashflows From Investing Activities | — | 8,000USD | 5,000,000USD | -5,000,000USD | — | — | — | — |
| Other Cashflows From Financing Activities | — | 33,654,000USD | 46,452,000USD | 423,000USD | 259,000USD | 17,000USD | -1,125,000USD | — |
| Unclassified Financing Cash Flow | — | -33,654,000USD | -46,452,000USD | — | — | — | 1,125,000USD | — |
| Investments | — | — | -37,508,000USD | -5,005,000USD | -24,000USD | 0USD | 0USD | 0USD |
| Unclassified Investing Cash Flow | — | — | -4,992,000USD | 5,005,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 6,326,000USD | 8,984,000USD | 5,296,000USD | 4,429,000USD | 5,410,000USD | 8,714,000USD | 2,698,000USD | 509,000USD |
| Depreciation | 420,000USD | 108,000USD | 94,000USD | 66,000USD | 109,000USD | 38,000USD | 52,000USD | 69,000USD |
| Stock Based Compensation | 404,000USD | 459,000USD | 473,000USD | 363,000USD | 452,000USD | 78,000USD | 182,000USD | 293,000USD |
| Other Non Cash Items | 2,130,000USD | 3,000USD | 360,000USD | 45,000USD | 452,000USD | 29,000USD | 220,000USD | -424,000USD |
| Change To Account Receivables | 210,000USD | 361,000USD | -882,000USD | 247,000USD | 974,000USD | 297,000USD | -505,000USD | 1,334,000USD |
| Change To Inventory | -582,000USD | -2,109,000USD | 1,026,000USD | -2,636,000USD | -2,945,000USD | -329,000USD | 502,000USD | -707,000USD |
| Change In Working Capital | -960,000USD | 56,000USD | -2,003,000USD | -773,000USD | -1,001,000USD | -3,060,000USD | -709,000USD | 104,000USD |
| Total Cash From Operating Activities | 7,439,000USD | 9,610,000USD | 4,220,000USD | 4,130,000USD | 4,480,000USD | 5,721,000USD | 2,261,000USD | 258,000USD |
| Capital Expenditures | -42,000USD | -10,000USD | -106,000USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | 7,397,000USD | 9,600,000USD | 4,114,000USD | 4,130,000USD | 4,480,000USD | 5,721,000USD | 2,261,000USD | 258,000USD |
| Total Cashflows From Investing Activities | -42,542,000USD | -10,000USD | -35,993,000USD | -529,000USD | -529,000USD | -529,000USD | -529,000USD | 4,000USD |
| Net Borrowings | 31,404,000USD | -7,000,000USD | 20,125,000USD | 0USD | 0USD | 450,000USD | -500,000USD | -1,865,000USD |
| Total Cash From Financing Activities | 32,086,000USD | -6,983,000USD | 20,296,000USD | -750,000USD | -390,000USD | 350,000USD | -2,255,000USD | -1,265,000USD |
| Change In Cash | -2,874,000USD | 2,622,000USD | -11,379,000USD | 3,380,000USD | 3,561,000USD | 6,071,000USD | 6,000USD | -1,003,000USD |
| Begin Period Cash Flow | 4,520,000USD | 1,898,000USD | 13,277,000USD | 9,897,000USD | 6,336,000USD | 265,000USD | 259,000USD | 1,262,000USD |
| End Period Cash Flow | 1,646,000USD | 4,520,000USD | 1,898,000USD | 13,277,000USD | 9,897,000USD | 6,336,000USD | 265,000USD | 259,000USD |
| Other Cashflows From Investing Activities | -42,500,000USD | — | -18,788,000USD | -529,000,000USD | — | — | — | 4,000USD |
| Other Cashflows From Financing Activities | 32,086,000USD | 17,000USD | 171,000USD | 29,000USD | — | 1,372,000USD | 229,000USD | 1,200,000USD |
| Unclassified Financing Cash Flow | -31,404,000USD | — | — | — | — | — | — | -1,137,000USD |
| Investments | — | -10,000USD | -18,984,000USD | -17,099,000USD | -529,000USD | -529,000USD | 0USD | 4,000USD |
| Sale Purchase Of Stock | — | — | 0USD | -779,000USD | -444,000USD | -171,000USD | -1,692,000USD | 600,000USD |
| Unclassified Investing Cash Flow | — | — | 1,885,000USD | 545,570,000USD | — | — | — | — |
| Change To Liabilities | — | — | — | 255,000USD | 928,000USD | -3,097,000USD | -857,000USD | -538,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 3,380,000USD | — | 6,071,000USD | 6,000USD | -1,003,000USD |
| Dividends Paid | — | — | — | — | — | -450,000USD | -63,000USD | -63,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | — | 0USD | 600,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Geography | International | 1,189,000 | USD | 0001437749-26-016875 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 24,136,000 | USD | 0001437749-26-016875 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Irwin | 12,849,000 | USD | 0001437749-26-016875 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Legacy Fit Life | 12,476,000 | USD | 0001437749-26-016875 |
| Q4 2025Quarterly · 2025-12-31 | Geography | International | 1,654,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | United States | 24,256,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | International | 4,058,000 | USD | 0001437749-26-010680 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 77,400,000 | USD | 0001437749-26-010680 |
| FY 2025Yearly · 2025-12-31 | Segment | Irwin | 0 | USD | 0001437749-26-016875 |
| FY 2025Yearly · 2025-12-31 | Segment | Legacy Fit Life | 15,936,000 | USD | 0001437749-26-016875 |
| Q3 2025Quarterly · 2025-09-30 | Geography | International | 1,129,000 | USD | 0001437749-25-034607 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 22,356,000 | USD | 0001437749-25-034607 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Irwin | 6,821,000 | USD | 0001437749-25-034607 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Legacy Fit Life | 12,855,000 | USD | 0001437749-25-034607 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Muscle Pharm | 3,809,000 | USD | 0001437749-25-034607 |
| Q2 2025Quarterly · 2025-06-30 | Geography | International | 643,000 | USD | 0001437749-25-026661 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 15,484,000 | USD | 0001437749-25-026661 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Legacy Fit Life | 7,303,000 | USD | 0001437749-25-026661 |
| Q2 2025Quarterly · 2025-06-30 | Segment | MRC | 6,269,000 | USD | 0001437749-25-026661 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Muscle Pharm | 2,555,000 | USD | 0001437749-25-026661 |
| Q1 2025Quarterly · 2025-03-31 | Geography | International | 632,000 | USD | 0001437749-26-016875 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 15,304,000 | USD | 0001437749-26-016875 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Legacy Fit Life | 7,299,000 | USD | 0001437749-25-016990 |
| Q1 2025Quarterly · 2025-03-31 | Segment | MRC | 6,674,000 | USD | 0001437749-25-016990 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Muscle Pharm | 1,963,000 | USD | 0001437749-25-016990 |
| Q4 2024Quarterly · 2024-12-31 | Geography | International | 875,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 14,138,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Legacy Fit Life | 5,322,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | MRC | 6,872,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Muscle Pharm | 2,819,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | International | 2,995,000 | USD | 0001437749-26-010680 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 61,474,000 | USD | 0001437749-26-010680 |
| FY 2024Yearly · 2024-12-31 | Segment | Legacy Fit Life | 25,387,000 | USD | 0001437749-25-009469 |
| FY 2024Yearly · 2024-12-31 | Segment | MRC | 29,036,000 | USD | 0001437749-25-009469 |
| FY 2024Yearly · 2024-12-31 | Segment | Muscle Pharm | 10,046,000 | USD | 0001437749-25-009469 |
| Q3 2024Quarterly · 2024-09-30 | Geography | International | 747,000 | USD | 0001437749-25-034607 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 15,230,000 | USD | 0001437749-25-034607 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Irwin | 0 | USD | 0001437749-25-034607 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Legacy Fit Life | 13,512,000 | USD | 0001437749-25-034607 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Muscle Pharm | 2,465,000 | USD | 0001437749-25-034607 |
| Q2 2024Quarterly · 2024-06-30 | Geography | International | 668,000 | USD | 0001437749-25-026661 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United States | 16,262,000 | USD | 0001437749-25-026661 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Legacy Fit Life | 6,802,000 | USD | 0001437749-25-026661 |
| Q2 2024Quarterly · 2024-06-30 | Segment | MRC | 7,461,000 | USD | 0001437749-25-026661 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Muscle Pharm | 2,667,000 | USD | 0001437749-25-026661 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Legacy Fit Life | 6,961,000 | USD | 0001437749-25-016990 |
| Q1 2024Quarterly · 2024-03-31 | Segment | MRC | 7,493,000 | USD | 0001437749-25-016990 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Muscle Pharm | 2,095,000 | USD | 0001437749-25-016990 |
| FY 2023Yearly · 2023-12-31 | Geography | International | 3,710,000 | USD | 0001437749-25-009469 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 48,990,000 | USD | 0001437749-25-009469 |
| FY 2023Yearly · 2023-12-31 | Segment | Legacy Fit Life | 28,077,000 | USD | 0001437749-25-009469 |
| FY 2023Yearly · 2023-12-31 | Segment | MRC | 24,370,000 | USD | 0001437749-25-009469 |
| FY 2023Yearly · 2023-12-31 | Segment | Muscle Pharm | 253,000 | USD | 0001437749-25-009469 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.